peptide elongation factor 2 has been researched along with Glomerulonephritis, Membranous in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allegri, L; Argentiero, L; Bruschi, M; Candiano, G; Carnevali, ML; Garibotto, G; Gatti, R; Gesualdo, L; Ghiggeri, GM; Magistroni, R; Murtas, C; Petretto, A; Prunotto, M; Ravani, P; Scolari, F | 1 |
1 other study(ies) available for peptide elongation factor 2 and Glomerulonephritis, Membranous
| Article | Year |
|---|---|
Direct characterization of target podocyte antigens and auto-antibodies in human membranous glomerulonephritis: Alfa-enolase and borderline antigens.
Topics: Adult; Aged; Autoantibodies; Autoantigens; Complement Membrane Attack Complex; Female; Glomerulonephritis, Membranous; Glycine-tRNA Ligase; Humans; Immunoglobulin G; Kidney Glomerulus; Laser Capture Microdissection; Male; Middle Aged; Peptide Elongation Factor 2; Phosphopyruvate Hydratase; Podocytes | 2011 |